PA live! (WBRE) — 28/22’s NEPA’s Children First Initiative is all about setting the next generation of northeast and central ...

An upcoming clinical trial will test whether empagliflozin might be able to improve heart health in pulmonary arterial ...

Recognising excellence in endocrinology, ESE announces the winners of its prestigious Awards for 2025 The European Society of ...

The overall prevalence of diabetes in the Jammu region is 18.9 per cent, with an alarming 26.5 per cent in urban areas and 14 ...

The overall prevalence of diabetes in Jammu is 18.9 per cent, with an alarming 26.5 per cent in urban areas and 14.5 per cent in rural areas, a study had revealed. The Indian Council of Medical ...

Not everybody loses the same amount of weight on medications such as Ozempic and Saxenda—treatment indication, dosage, and ...

MASLD in pediatric obesity was linked to an increased risk for youth-onset type 2 diabetes, especially in the presence of ...

In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...

After years of struggle, patients with diabetes have won major victories for access to affordable insulin, but the fight is not over.

In partnership with the Chronic Disease Research Foundation, the three-year research fellowship at King's College London will ...

Type 1 diabetes (also known as diabetes mellitus) is an autoimmune disease in which immune cells attack and destroy the insulin-producing cells of the pancreas. The loss of insulin leads to the ...

In a recent study, Madras Diabetes Research Foundation and Indian Council of Medical Research estimated about 25 million Indians are pre-diabetic. And according to the International Diabetes ...